造血
生物
突变体
干细胞
谱系(遗传)
细胞谱系
癌症研究
细胞生物学
肿瘤坏死因子α
受体
突变
干细胞因子
遗传学
细胞分化
免疫学
基因
作者
Jennifer M. SanMiguel,Elizabeth Eudy,Matthew A. Loberg,Kira Young,Jayna J. Mistry,Kristina D. Mujica,Logan S. Schwartz,Timothy M. Stearns,Grant A. Challen,Jennifer J. Trowbridge
出处
期刊:Cancer Discovery
[American Association for Cancer Research]
日期:2022-09-28
卷期号:12 (12): 2763-2773
被引量:61
标识
DOI:10.1158/2159-8290.cd-22-0086
摘要
Clonal hematopoiesis resulting from the enhanced fitness of mutant hematopoietic stem cells (HSC) associates with both favorable and unfavorable health outcomes related to the types of mature mutant blood cells produced, but how this lineage output is regulated is unclear. Using a mouse model of a clonal hematopoiesis-associated mutation, DNMT3AR882/+ (Dnmt3aR878H/+), we found that aging-induced TNFα signaling promoted the selective advantage of mutant HSCs and stimulated the production of mutant B lymphoid cells. The genetic loss of the TNFα receptor TNFR1 ablated the selective advantage of mutant HSCs without altering their lineage output, whereas the loss of TNFR2 resulted in the overproduction of mutant myeloid cells without altering HSC fitness. These results nominate TNFR1 as a target to reduce clonal hematopoiesis and the risk of associated diseases and support a model in which clone size and mature blood lineage production can be independently controlled to modulate favorable and unfavorable clonal hematopoiesis outcomes. Through the identification and dissection of TNFα signaling as a key driver of murine Dnmt3a-mutant hematopoiesis, we report the discovery that clone size and production of specific mature blood cell types can be independently regulated. See related commentary by Niño and Pietras, p. 2724. This article is highlighted in the In This Issue feature, p. 2711.
科研通智能强力驱动
Strongly Powered by AbleSci AI